MELK is a novel therapeutic target in high-risk neuroblastoma S Guan, J Lu, Y Zhao, Y Yu, H Li, Z Chen, Z Shi, H Liang, M Wang, K Guo, ... Oncotarget 9 (2), 2591, 2018 | 26 | 2018 |
TAK1 inhibitor 5Z-7-oxozeaenol sensitizes cervical cancer to doxorubicin-induced apoptosis S Guan, J Lu, Y Zhao, SE Woodfield, H Zhang, X Xu, Y Yu, J Zhao, ... Oncotarget 8 (20), 33666, 2017 | 24 | 2017 |